- cross-posted to:
- science@lemmit.online
- science@lemmy.world
- cross-posted to:
- science@lemmit.online
- science@lemmy.world
This is an automated archive made by the Lemmit Bot.
The original was posted on /r/upliftingnews by /u/bangsphoto on 2024-02-02 05:46:55.
Original Title: Single-dose treatment of CRISPR gene therapy for hereditary swelling disorder transformed lives of patients with potentially deadly condition in first human trial. The results from the first patients are published in the New England Journal of Medicine.
You must log in or register to comment.